Müller, Helge H.O. (2017) Effective and underprescribed: what about clozapine? Mental illness, 9 (2). ISSN 2036-7457
|
- Published Version
Volltext (505Kb) |
Abstract
Clinical psychiatry, especially pharmacological-based treatment regimens still face the problem of high rates of partial or non-responders to the various treatment strategies. So in schizophrenia, a serious psychiatric disease with regard to overall impairment of patients up to three-quarters will experience a relapse after their first episode and one-fifth is facing long-term symptoms often leading to disability and dramatically reduced quality of life and psychosocial outcome.
Item Type: | Article |
---|---|
Additional Information: | Publiziert mit Hilfe des DFG-geförderten Open Access-Publikationsfonds der Carl von Ossietzky Universität Oldenburg. |
Uncontrolled Keywords: | schizophrenia; clozapine |
Subjects: | Philosophy and psychology > Psychology Technology, medicine, applied sciences > Medicine and health |
Divisions: | Faculty of Medicine and Health Sciences > Department of Human Medicine |
Date Deposited: | 15 Feb 2018 14:02 |
Last Modified: | 27 Feb 2018 10:03 |
URI: | https://oops.uni-oldenburg.de/id/eprint/3497 |
URN: | urn:nbn:de:gbv:715-oops-35785 |
DOI: | 10.4081/mi.2017.7193 |
Nutzungslizenz: |
Actions (login required)
View Item |